Trump administration says lower prices for 15 Medicare drugs will save taxpayers billions of dollars
The latest negotiated prices apply to some of the prescription medications on which Medicare spends the most money.
Medicare
-
American Senior Communities agrees to pay $5.6M to settle false claims allegations
American Senior Communities, the largest nursing home company in Indiana, has agreed to the settlement to resolve allegations that it violated federal laws by submitting false claims to the Medicare program.
Read More -
20 Indiana hospitals docked for high rates of patient injuries, infections
The fines are one way Medicare is clamping down on hospitals, using penalties and incentives authorized by the Affordable Care Act to push for better outcomes, fewer safety problems and a lower number of readmissions.
Read More -
Eli Lilly’s Alzheimer’s drug hits roadblock
The FDA has agreed to speed up review of donanemab, but the Centers for Medicare and Medicaid Services is moving to limit reimbursement for drugs in this class to only patients in clinical trials.
Read More -
Insurers push hard to win Medicare Advantage customers
In Indiana last year, dozens of insurers across the state rolled out plans hoping to get a sizable piece of the fast-growing market.
Read More
Articles
Indianapolis lab agrees to pay more than $9M in settlement over improper Medicare claims
The government says the lab billed Medicare for tests that were unnecessary or tied to improper referral arrangements.
Rising health care costs prompt small businesses to find creative solutions
Business leaders say health insurance is causing heartburn among many small employers, forcing some to consider dropping coverage altogether.
UPDATE: White House nears deal with Lilly, Novo to slash obesity drug prices for Medicare
The deal is seen as one of the most significant in the administration’s current drug-pricing push, given the potential effect on public health and spending on health care.
Medicaid work requirements delayed until 2027 following federal action
Other parts of Indiana’s HIP 3.0 proposal are still under consideration, including an expansion on provider taxes, cost-sharing requirements and wellness incentives.
New bill seeks to restore millions in Medicaid funding to Indiana hospitals
Hospital leaders who spoke with Inside INdiana Business emphasized the bill wouldn’t increase funding, it would give hospitals access to funding that’s already been allocated.
Medicare, Medicaid plans to experiment with covering weight loss drugs
Trump administration officials have offered mixed messages about GLP-1s and whether they should be relied upon for weight loss by obese and overweight Americans.
11 Eastern Europeans charged in $10.6B Medicare fraud scheme
Prosecutors say the organization bought more than 30 previously legitimate U.S. companies and turned them from lawful businesses into consistent vehicles for fraud.
RFK Jr., Dr. Oz to join Braun to launch ‘Make Indiana Healthy Again’ campaign
Gov. Mike Braun’s new initiative borrows from Kennedy’s “Make America Healthy Again” slogan, which Kennedy, the U.S. health secretary, borrowed from President Donald Trump’s campaign.
Department of Health and Human Services to lay off 10,000 workers in major restructuring
The plan means cuts at the Food and Drug Administration, the Centers for Disease Control and Prevention, the National Institutes of Health, and the Centers for Medicare and Medicaid Services.
Lilly shares get bump from pricey Biden proposal for covering weight-loss drugs
While the proposed rule would give millions of people access to weekly injectables like Eli Lilly and Co.’s Zepbound that have helped people shed pounds, it would cost taxpayers as much as $35 billion over the next decade.
Elevance Health sues feds over ‘arbitrary and capricious’ star ratings for Medicare Advantage plans
At stake are billions of dollars in bonuses that the Centers for Medicare and Medicaid Services awards to insurers that achieve a certain start rating on their Medicare Advantage scores.
Proposed Medicare cuts put squeeze on doctors
Last month, the federal Medicare program proposed a 2.9% cut to physician pay for 2025. That marked the fifth straight year that regulators proposed cutting payments to doctors for thousands of services, from stitching a wound to replacing a knee.
Medicare cutting prices of 64 drugs that outpaced inflation
Some of America’s seniors will see their out of pocket costs fall for more than five dozen drugs—including treatments for osteoporosis and cancer—as part of the White House’s crackdown on rising pharmaceutical prices.
Medicare, Social Security go-broke dates delayed in ‘measure of good news’
An improving economy has contributed to changed projected depletion dates, according to the annual Social Security and Medicare trustees report Monday. Still, officials warned that policy changes are needed lest the programs become unable to pay full benefits to retiring Americans.
Biden sees $35 price cap for insulin as pivotal campaign issue
Rarely a day goes without President Joe Biden mentioning insulin prices and promoting a $35 price cap for the medication for Americans on Medicare. The reality is more complicated.
Legislative push brewing to make new weight loss drugs more accessible
Obesity drugs like Wegovy and Eli Lilly’s Zepbound are showing promising results in helping people shed pounds. But a law bans Medicare from paying for weight loss drugs. Now, drugmakers and a bipartisan coalition of lawmakers are gearing up to push for that to change next year.
Get ready for the annual blitz of Medicare Advantage ads
If history is any guide, there will be plenty of high-budget television ads from national and local insurance plans looking to boost their rolls. But the Centers for Medicare & Medicaid Services is cracking down on misleading pitches.
Eli Lilly’s Jardiance among 10 prescription drugs chosen for price negotiations
The Biden administration is targeting diabetes treatment Jardiance and nine other medications for Medicare’s first-ever drug price negotiations as it seeks to lower medical costs for Americans.
Drugmakers warn new law will deter discoveries
David Ricks, CEO of Indianapolis-based drugmaker Eli Lilly and Co., is turning up the volume on his concerns over a new law that would allow Medicare, for the first time, to negotiate drug prices.